Related Experiment Video
Updated: Aug 7, 2026

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
Cellular distribution of human tissue kallikreins: immunohistochemical localization
Constantina D Petraki1, Panagiotis A Papanastasiou, Vassiliki N Karavana
1Department of Pathology, Evangelismos Hospital, GR-10676 Athens, Greece, and Depament of Laboratory Medicine and Pathobiology, University of Toronto, Canada.
Insights
This study examined human kallikreins (hKs) in normal and malignant tissues, finding they are widely expressed and secreted, suggesting common regulation. Most hKs were detected in adenocarcinomas, with potential prognostic value explored in various cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Human kallikreins (hKs) are a large family of serine proteases with diverse functions.
- Understanding the expression patterns of hKs is crucial for elucidating their roles in normal physiology and disease.
Purpose of the Study:
- To investigate the immunohistochemical expression (IE) of eight non-tissue-specific human kallikreins (hK5, 6, 7, 10, 11, 12, 13, and 14) in normal and malignant human tissues.
- To compare the expression patterns of these hKs across different tissues and explore their potential tissue specificity.
- To evaluate the expression of hKs in various carcinomas and assess their prognostic value.
Main Methods:
- Immunohistochemistry (IE) was employed to detect the expression of eight non-tissue-specific hKs in normal and malignant tissues.
- Results were correlated with existing data from RT-PCR and ELISA assays.
- Prognostic value was assessed in series of prostate, renal cell, colon, and urothelial carcinomas.
Main Results:
- The IE of the studied hKs was consistently cytoplasmic and showed characteristic patterns in certain tissues.
- No major differences in IE were observed among the studied hKs across different tissues, suggesting a common regulatory mechanism.
- hKs were detected in a variety of tissues, with glandular epithelia and their secretions being primary sites, indicating secretion.
- Tumors derived from tissues expressing kallikreins tested positive, with most hKs expressed in adenocarcinomas.
Conclusions:
- Non-tissue-specific human kallikreins are widely expressed and secreted in various normal tissues, indicating a shared regulatory pathway.
- The expression of these hKs in adenocarcinomas suggests their involvement in cancer development.
- Further investigation into the prognostic value of specific hKs in different cancer types is warranted.
Abstract:
We have studied the immunohistochemical expression (IE) of eight non-tissue-specific human kallikreins (hKs) (hK5, 6, 7, 10, 11, 12, 13, and 14) in different normal tissues. The IE was always cytoplasmic, showing a characteristic pattern in some tissues. Comparison of the IE of all hKs studied in the different tissues revealed no major differences, suggesting that they share a common mode of regulation. Furthermore, hKs were immunohistochemically revealed in a variety of tissues, indicating that no protein is tissue-specific (except for hK2 and hK3, which have tissue-restricted expression). In general, our results correspond well with data from RT-PCR and ELISA assays. Glandular epithelia constitute the main kallikrein IE sites, and the staining in their secretions confirms that these proteases are secreted. A variety of other tissues express the proteins as well. We have also immunohistochemically evaluated all the above hKs in several malignant tissues. Tumors arising from tissues expressing kallikreins tested positive. Corresponding to the IE in normal glandular tissues, most hKs were expressed in adenocarcinomas. The prognostic value of several hKs was studied in series of prostate, renal cell, colon and urothelial carcinomas.
More Related Videos
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

